Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Retained Deficit | Accumulated Other Comprehensive Loss |
Balance at beginning of period (in shares) at Dec. 31, 2022 | | 29,932,668 | | | |
Balance at beginning of period at Dec. 31, 2022 | $ (390,861) | $ 300 | $ 2,797 | $ (393,321) | $ (637) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 15,669 | | | 15,669 | |
Shares issued under stock plans (in shares) | | 49,817 | | | |
Shares issued under stock plans | 111 | | 111 | | |
Tax payments for restricted stock upon vesting (in shares) | | (13,613) | | | |
Tax payments for restricted stock upon vesting | (2,292) | | | (2,292) | |
Stock-based compensation expense, net of forfeitures | 3,345 | | 3,345 | | |
Dividends declared on common stock and equivalents | (5,909) | | (5,444) | (465) | |
Currency translation adjustment | 147 | | | | 147 |
Balance at end of period (in shares) at Apr. 01, 2023 | | 29,968,872 | | | |
Balance at end of period at Apr. 01, 2023 | (379,790) | $ 300 | 809 | (380,409) | (490) |
Balance at beginning of period (in shares) at Dec. 31, 2022 | | 29,932,668 | | | |
Balance at beginning of period at Dec. 31, 2022 | (390,861) | $ 300 | 2,797 | (393,321) | (637) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 31,850 | | | | |
Currency translation adjustment | 276 | | | | |
Balance at end of period (in shares) at Jul. 01, 2023 | | 29,977,614 | | | |
Balance at end of period at Jul. 01, 2023 | (365,351) | $ 300 | 2,038 | (367,327) | (362) |
Balance at beginning of period (in shares) at Apr. 01, 2023 | | 29,968,872 | | | |
Balance at beginning of period at Apr. 01, 2023 | (379,790) | $ 300 | 809 | (380,409) | (490) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 16,181 | | | 16,181 | |
Shares issued under stock plans (in shares) | | 9,084 | | | |
Shares issued under stock plans | 362 | | 362 | | |
Tax payments for restricted stock upon vesting (in shares) | | (342) | | | |
Tax payments for restricted stock upon vesting | (69) | | | (69) | |
Stock-based compensation expense, net of forfeitures | 3,546 | | 3,546 | | |
Dividends declared on common stock and equivalents | (5,709) | | (2,679) | (3,030) | |
Currency translation adjustment | 128 | | | | 128 |
Balance at end of period (in shares) at Jul. 01, 2023 | | 29,977,614 | | | |
Balance at end of period at Jul. 01, 2023 | $ (365,351) | $ 300 | 2,038 | (367,327) | (362) |
Balance at beginning of period (in shares) at Dec. 30, 2023 | 29,337,920 | 29,337,920 | | | |
Balance at beginning of period at Dec. 30, 2023 | $ (457,366) | $ 293 | 2,676 | (459,994) | (341) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 28,747 | | | 28,747 | |
Shares issued under stock plans (in shares) | | 42,918 | | | |
Shares issued under stock plans | 708 | $ 1 | 707 | | |
Tax payments for restricted stock upon vesting (in shares) | | (10,860) | | | |
Tax payments for restricted stock upon vesting | (3,717) | | | (3,717) | |
Stock-based compensation expense, net of forfeitures | 3,812 | | 3,812 | | |
Dividends declared on common stock and equivalents | (6,539) | | (6,277) | (262) | |
Currency translation adjustment | (24) | | | | (24) |
Balance at end of period (in shares) at Mar. 30, 2024 | | 29,369,978 | | | |
Balance at end of period at Mar. 30, 2024 | $ (434,379) | $ 294 | 918 | (435,226) | (365) |
Balance at beginning of period (in shares) at Dec. 30, 2023 | 29,337,920 | 29,337,920 | | | |
Balance at beginning of period at Dec. 30, 2023 | $ (457,366) | $ 293 | 2,676 | (459,994) | (341) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 56,232 | | | | |
Currency translation adjustment | $ (36) | | | | |
Balance at end of period (in shares) at Jun. 29, 2024 | 29,304,401 | 29,304,401 | | | |
Balance at end of period at Jun. 29, 2024 | $ (437,541) | $ 293 | 1,869 | (439,326) | (377) |
Balance at beginning of period (in shares) at Mar. 30, 2024 | | 29,369,978 | | | |
Balance at beginning of period at Mar. 30, 2024 | (434,379) | $ 294 | 918 | (435,226) | (365) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net income | 27,485 | | | 27,485 | |
Shares issued under stock plans (in shares) | | 11,323 | | | |
Shares issued under stock plans | 546 | | 546 | | |
Purchases of common stock (in shares) | | (75,862) | | | |
Purchases of common stock | (29,220) | $ (1) | (4,304) | (24,915) | |
Tax payments for restricted stock upon vesting (in shares) | | (1,038) | | | |
Tax payments for restricted stock upon vesting | (401) | | | (401) | |
Stock-based compensation expense, net of forfeitures | 4,926 | | 4,926 | | |
Dividends declared on common stock and equivalents | (6,486) | | (217) | (6,269) | |
Currency translation adjustment | $ (12) | | | | (12) |
Balance at end of period (in shares) at Jun. 29, 2024 | 29,304,401 | 29,304,401 | | | |
Balance at end of period at Jun. 29, 2024 | $ (437,541) | $ 293 | $ 1,869 | $ (439,326) | $ (377) |